Nevertheless, our study strongly supports the reported poor prognosis of MSI-negative colorectal cancers with KRAS or BRAF mutations6, 7, 8, 9, 10, 11 compared with MSI-negative colorectal cancers wild-type for these genes and unselected MSI-positive colorectal cancers. This evidence concerns the gene KRAS and colorectal cancer.